Companies › Juventas Cell Therapy
3 active drug programs in 6 registered trials: 3 Phase 2, 3 Phase 1; Oncology, Hematology; next expected readout Dec 2026.
Open in Phaseline: competitors, likelihood bands and readouts Company report
| Drug | Target | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|
| CNCT19 anti-CD19 CAR-T cell therapy | CD19 | Phase 2 | Non-Hodgkin's Lymphoma; Relapsed or Refractory Acute Lymphoblastic Leukemia; B-cell Acute Lymphoblastic Leukemia | Dec 2026 |
| Inaticabtagene autoleucel Injection CD19-directed CAR-T cells (autologous 2nd generation) | – | Phase 1 | Autoimmune Thrombocytopenia; B-cell Acute Lymphoblastic Leukemia | Dec 2027 |
| HY001N Cell Injection CAR-T cell therapy | – | Phase 1 | Autoimmune Hemolytic Anemia (AIHA) | Sep 2028 |
| Registry id | Drug | Phase | Conditions | Area | Expected readout |
|---|---|---|---|---|---|
| NCT04586478 | CNCT19 | Phase 2 | Non-Hodgkin's Lymphoma | Oncology | Mar 2024 |
| NCT04684147 | CNCT19 | Phase 2 | Relapsed or Refractory Acute Lymphoblastic Leukemia | Oncology | Dec 2026 |
| NCT05667506 | CNCT19 | Phase 1 | B-cell Acute Lymphoblastic Leukemia | Oncology | May 2027 |
| NCT06826430 | Inaticabtagene autoleucel Injection | Phase 1 | Autoimmune Thrombocytopenia | Hematology | Dec 2027 |
| NCT06608732 | Inaticabtagene autoleucel Injection | Phase 2 | B-cell Acute Lymphoblastic Leukemia | Oncology | Jul 2028 |
| NCT07748533 | HY001N Cell Injection | Phase 1 | Autoimmune Hemolytic Anemia (AIHA) | Hematology | Sep 2028 |
Beijing Yongtai Ruike Biotechnology Company iCell Gene Therapeutics Grit Biotechnology Shanghai Ming Ju Biotechnology PersonGen BioTherapeutics (Suzhou)
Pipelines of the same shape: areas, drug types, target families, stage and cash runway.
Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.